First Time Loading...

Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 6.53 CHF 0.77% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

KURN Price Targets Summary
Kuros Biosciences AG

Wall Street analysts forecast KURN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KURN is 20.05 CHF .

KURN Lowest Forecast
Wall Street Target
Not Available
KURN Average Forecast
Wall Street Target
20.05 CHF
207% Upside
KURN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
20.05 CHF
207% Upside
Highest
Price Target
Not Available
Kuros Biosciences AG Competitors:
Price Targets
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
AVCT
Avacta Group PLC
103% Upside
Z
ZURA
Zura Bio Ltd
284% Upside
TNGX
Tango Therapeutics Inc
136% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
AVCT
Avacta Group PLC
103% Upside
Z
ZURA
Zura Bio Ltd
284% Upside
TNGX
Tango Therapeutics Inc
136% Upside
M
MGX
Metagenomi Inc
272% Upside
603087
Gan & Lee Pharmaceuticals
26% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
DSGN
Design Therapeutics Inc
30% Upside

Revenue
Forecast

Revenue Estimate
Kuros Biosciences AG

Revenue forecast
is not available for
Kuros Biosciences AG

Operating Income
Forecast

Operating Income Estimate
Kuros Biosciences AG

Operating Income forecast
is not available for
Kuros Biosciences AG

Net Income
Forecast

Net Income Estimate
Kuros Biosciences AG

Net Income forecast
is not available for
Kuros Biosciences AG

See Also

Summary
KURN intrinsic value, competitors valuation, and company profile.
DCF Valuation
KURN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KURN stock valuation using valuation multiples.
Wall Street Estimates
KURN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KURN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KURN's stock price target?
Price Target
20.05 CHF

According to Wall Street analysts, the average 1-year price target for KURN is 20.05 CHF .

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.